Search results

Search for "agonist" in Full Text gives 81 result(s) in Beilstein Journal of Organic Chemistry.

Synthesis and characterization of Sant-75 derivatives as Hedgehog-pathway inhibitors

  • Chao Che,
  • Song Li,
  • Bo Yang,
  • Shengchang Xin,
  • Zhixiong Yu,
  • Taofeng Shao,
  • Chuanye Tao,
  • Shuo Lin and
  • Zhen Yang

Beilstein J. Org. Chem. 2012, 8, 841–849, doi:10.3762/bjoc.8.94

Graphical Abstract
  • carcinoma. In addition, a number of man-made inhibitors with a Smo binding affinity have been identified and reported [2][28][29][30][31][32][33][34], and some of them have entered phase I development. SAG is a synthetic Hh pathway agonist that directly targets Smo in a manner that antagonizes cyclopamine
  • action, and thus it may serve as an interesting scaffold for drug development [35][36]. Recently, we have identified a Smo antagonist Sant-75 through zebrafish-based screening of a SAG-derived chemical library [37]. Interestingly, this antagonist differs from agonist SAG only in the chain length of the
PDF
Album
Supp Info
Full Research Paper
Published 06 Jun 2012

Novel synthesis of pseudopeptides bearing a difluoromethyl group by Ugi reaction and desulfanylation

  • Jingjing Wu,
  • Hui Li and
  • Song Cao

Beilstein J. Org. Chem. 2011, 7, 1070–1074, doi:10.3762/bjoc.7.123

Graphical Abstract
  • reported of the preparation and bioassay of pseudopeptides and peptidomimetics bearing difluoromethyl groups. For example, compound I can act as bradykinin B1 antagonist or inverse agonist and can be used in the prevention of inflammation and pain [19]. Compound II is an inhibitor of microsomal
PDF
Album
Supp Info
Full Research Paper
Published 08 Aug 2011

An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals

  • Marcus Baumann,
  • Ian R. Baxendale,
  • Steven V. Ley and
  • Nikzad Nikbin

Beilstein J. Org. Chem. 2011, 7, 442–495, doi:10.3762/bjoc.7.57

Graphical Abstract
  • structure, mutation studies have shown that the AT2 antagonists such as losartan bind to an active site located within the membrane-bound part of the receptor, which is different to that of the peptide agonist. Further studies led to the discovery of valsartan, where the imidazole ring of losartan is
  • , and is part of the imidazopyridine class of pharmaceuticals. It is an agonist for the target receptor of γ-aminobutyric acid (GABA), an inhibitory neurotransmitter. Zolpidem binds to GABA receptors at the same site as typical benzodiazepines. This drug is preferred to benzodiazepines for long term use
  • , Arimidex) and 5-HT1 agonist triptan drugs such as rizatriptan (76, Maxalt) which are prescribed for migraine headaches. The large scale syntheses of all these compounds use the commercially available 1,2,4-triazolyl sodium salt 258 in an alkylation reaction with the corresponding benzyl bromide derivative
PDF
Album
Review
Published 18 Apr 2011

Palladium- and copper-mediated N-aryl bond formation reactions for the synthesis of biological active compounds

  • Carolin Fischer and
  • Burkhard Koenig

Beilstein J. Org. Chem. 2011, 7, 59–74, doi:10.3762/bjoc.7.10

Graphical Abstract
  • A-366833, a selective α4β2 neural nicotinic receptor agonist. A new route to oxcarbazepine. Synthesis of key intermediates for norepinephrine transporter (NET) inhibitors. N-Annulation yielding substituted indole for the synthesis of demethylasterriquinone A1. Palladium-catalysed double N-arylation
PDF
Album
Review
Published 14 Jan 2011

Transition- metal/Lewis acid free synthesis of acyl benzothiophenes via C-C bond forming reaction

  • Sarbani Pal,
  • Mohammad Ashrafuddin Khan,
  • P. Bindu and
  • P. K. Dubey

Beilstein J. Org. Chem. 2007, 3, No. 35, doi:10.1186/1860-5397-3-35

Graphical Abstract
  • , Raloxifene, [2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride (A, Figure 1), is representative of a class of compounds known as selective estrogen receptor modulators[1] (SERMs) that possess estrogen agonist-like actions on bone tissues and serum
PDF
Album
Supp Info
Preliminary Communication
Published 25 Oct 2007

8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor

  • Thomas A. Munro,
  • Katharine K. Duncan,
  • Richard J. Staples,
  • Wei Xu,
  • Lee-Yuan Liu-Chen,
  • Cécile Béguin,
  • William A. Carlezon Jr. and
  • Bruce M. Cohen

Beilstein J. Org. Chem. 2007, 3, No. 1, doi:10.1186/1860-5397-3-1

Graphical Abstract
  • hallucinogenic sage Salvia divinorum,[1] is a potent and selective κ opioid receptor (KOR) agonist.[2] Because it is the first known non-nitrogenous compound to have biologically significant actions at mammalian opioid receptors, 1a enables new approaches to studies of endogenous opioid receptor systems. KOR
PDF
Album
Supp Info
Full Research Paper
Published 09 Jan 2007
Other Beilstein-Institut Open Science Activities